Tetrahydroxy Stilbene Glycoside Reduces Abeta Deposition by Modulating Microglia Activation and via TREM2/PI3K/AKT Pathway in APP/PS1 Mice
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Ming Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease, Amyloid beta-Peptides, Stilbenes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fund of Beijing Shijitan Hospital, Capital Medical University.
Abstract (Originalsprache)
Tetrahydroxy stilbene glycoside (TSG), which is the primary active substance of Chinese herbal medicine called Polygonum multiflorum , has been acknowledged to alleviate Alzheimer's disease (AD)‐induced learning disorder in the transgene mice. Because the microglia activation is really important during the AD progression, herein, we determined the effects of TSG on AD neuropathology, microglia polarization and its underlying mechanism. We used APP/PS1 mice along with immunohistochemistry and immunofluorescence techniques to evaluate the function of TSG as 60, 120 and 180 mg/kg on Aβ deposition, neuronal loss and microglia polarization induced by AD. Additionally, we assessed the effects of TSG on TREM2 signalling using both molecular docking and Western blot analysis. TSG was found to promote neuronal survival and decrease Aβ deposition in APP/PS1 mice. Moreover, TSG reduced microglia M1 polarization and modulated the TREM2/PI3K/AKT signalling pathways. TSG could reduce neuronal impairment by mediating the microglia polarization by TREM2/PI3K/AKT signalling pathway in APP/PS1 mice and is a latent pharmacological research direction for the therapy in the patients with AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Institute of Basic Theory of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Anesthesiology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Yan Gao
Förderung
- National Natural Science Foundation of China
- Fund of Beijing Shijitan Hospital, Capital Medical University
Zitieren
APA
Li, M., Song, Q., Jie, S., Wang, C., Zhang, C., Chi, K., Gao, Y., & Li, T. (2025). Tetrahydroxy Stilbene Glycoside Reduces Abeta Deposition by Modulating Microglia Activation and via TREM2/PI3K/AKT Pathway in APP/PS1 Mice. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70008
Vancouver
Li M, Song Q, Jie S, Wang C, Zhang C, Chi K, et al. Tetrahydroxy Stilbene Glycoside Reduces Abeta Deposition by Modulating Microglia Activation and via TREM2/PI3K/AKT Pathway in APP/PS1 Mice. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70008
BibTeX
@article{Li2025,
author = {Li, Ming and Song, Qihan and Jie, Shanshan and Wang, Chenchen and Zhang, Can and Chi, Kexin and Gao, Yan and Li, Tianzuo},
title = {Tetrahydroxy Stilbene Glycoside Reduces Abeta Deposition by Modulating Microglia Activation and via TREM2/PI3K/AKT Pathway in APP/PS1 Mice},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70008}
}
EUVIMED